184 related articles for article (PubMed ID: 38560200)
21. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
22. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
Jin D; Yuan L; Li F; Wang S; Mao Y
BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
[TBL] [Abstract][Full Text] [Related]
23. AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.
Zhang J; Yin YT; Wu CH; Qiu RL; Jiang WJ; Deng XG; Li ZX
Dis Markers; 2019; 2019():8186091. PubMed ID: 31827645
[TBL] [Abstract][Full Text] [Related]
24. Hub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Lu J; Li R; Fang M; Ke S
Comput Math Methods Med; 2022; 2022():6027058. PubMed ID: 36238478
[TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
27.
Ma J; Gui H; Tang Y; Ding Y; Qian G; Yang M; Wang M; Song X; Lv H
Front Genet; 2021; 12():585058. PubMed ID: 33868359
[TBL] [Abstract][Full Text] [Related]
28. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Huang M; Long Y; Jin Y; Ya W; Meng D; Qin T; Su L; Zhou W; Wu J; Huang C; Huang Q
Transl Androl Urol; 2021 Mar; 10(3):1286-1301. PubMed ID: 33850763
[TBL] [Abstract][Full Text] [Related]
30. Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.
Wang X; Gao C; Feng F; Zhuang J; Liu L; Li H; Liu C; Wu J; Zheng X; Ding X; Sun C
Biomed Res Int; 2020; 2020():4078596. PubMed ID: 32775417
[TBL] [Abstract][Full Text] [Related]
31. Key LncRNAs Associated With Oxidative Stress Were Identified by GEO Database Data and Whole Blood Analysis of Intervertebral Disc Degeneration Patients.
Jiang X; Wu J; Guo C; Song W
Front Genet; 2022; 13():929843. PubMed ID: 35937989
[No Abstract] [Full Text] [Related]
32. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of lncRNA/circRNA-miRNA-mRNA in the proliferative phase of liver regeneration in mice with liver fibrosis.
Wang Q; Long Z; Zhu F; Li H; Xiang Z; Liang H; Wu Y; Dai X; Zhu Z
BMC Genomics; 2023 Jul; 24(1):417. PubMed ID: 37488484
[TBL] [Abstract][Full Text] [Related]
34. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
35. Whole transcriptome sequencing identifies key lncRNAs,circRNAs, and mRNAs for exploring the pathogenesis and therapeutic target of mouse pneumoconiosis.
Liu T; Su X; Kong X; Dong H; Wei Y; Wang Y; Wang C
Gene; 2024 Apr; 901():148169. PubMed ID: 38242381
[TBL] [Abstract][Full Text] [Related]
36. AK4P1 is a cancer-promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes.
Li L; Deng T; Zhang Q; Yang Y; Liu Y; Yuan L; Xie M
Oncol Lett; 2022 May; 23(5):163. PubMed ID: 35414829
[TBL] [Abstract][Full Text] [Related]
37. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract][Full Text] [Related]
39. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
